<?xml version="1.0" encoding="UTF-8"?>
<p>The global prevalence of HCV infection is estimated at 2–3%.[
 <xref rid="ref27" ref-type="bibr">27</xref>
 <xref rid="ref28" ref-type="bibr">28</xref>
 <xref rid="ref29" ref-type="bibr">29</xref>
 <xref rid="ref30" ref-type="bibr">30</xref>] The prevalence of HCV is highest in Africa and the Middle East. China, India, Egypt, Pakistan, and Indonesia account for approximately half of the global HCV-infected subjects.[
 <xref rid="ref31" ref-type="bibr">31</xref>
 <xref rid="ref32" ref-type="bibr">32</xref>
 <xref rid="ref33" ref-type="bibr">33</xref>
 <xref rid="ref34" ref-type="bibr">34</xref>] North America, Australia, Japan, and Northern and Western Europe report lower prevalence of HCV infection, with no country showing a rate &gt; 2%. Owing to the paucity of large-scale prevalence studies on hepatitis C in the general population of India, the reported prevalence rates are variable ranging from 0.09–2.02%.[
 <xref rid="ref35" ref-type="bibr">35</xref>]
</p>
